Facts
The UK Anti-Doping Limited ("UKAD") charged Daniel Maloney (the "Athlete") for an omission of the Anti-Doping Rules ("ADR"). On November 24, 2012, the Athlete competed at the British Weightlifting Association ("BWLA") Northern Open. He placed first position in the 105 kilogram class of the Event and was notified that he would be required to provide a urine sample for Doping Control purposes. He initially sought to leave without providing such a sample, but was advised by the Doping Control Personnel that he was obliged to do so. He then provided a sample. His sample tested positive on epitrenbolone (as trimethylsilyl derivative dehydro-product) and 17-epitrenbolone (as trimethylsilyl derivative oxidation product) (both metabolites of trenbolone) and methandienone and 17-epimethandienone (a metabolite of methandienone). On December 18, 2012, UK Anti-Doping issued a Notice of Charge to the Athlete, charging him with violations of both ADR 2.1 and 2.2 in respect of each of the Prohibited Substances (the “Charges”). The Athlete was also provisionally suspended, effective from 18 December 2012. The Athlete has made a prompt admission in respect of the Charges, and therefore avoids the application of ADR 10.6.1.
Decision
1. Anti-Doping Rule Violations in accordance with ADR 2.1 and 2.2 have been established in relation to the Prohibited Substances;
2. A period of Ineligibility of two years shall be the consequences imposed pursuant to Anti-Doping Rule 10.2;
3. That period of Ineligibility is deemed to have commenced as from 18 December 2012, and will end at midnight on December 17, 2014;
2. The Athlete’s status during this period of Ineligibility shall be as set out in Article 10.10:
